Echo IQ Concludes Presentation Regarding Application for Category III CPT Code for EchoSolv AS in the US, Shares Fall 18%

MT Newswires Live
2025/09/19

Echo IQ (ASX:EIQ) said it concluded its presentation to the American Medical Association's CPT editorial panel meeting regarding its application for a category III current procedural technology (CPT) code for its EchoSolv aortic stenosis (AS) artificial intelligence imaging technology in the US, according to a Friday Australian bourse filing.

It added that it had not received an indication of the panel votes at the time of the filing, despite media speculation. Results will be posted by the association in the coming two to four weeks.

The firm's shares fell 18% in recent trading on Friday.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10